vs
Side-by-side financial comparison of Dexcom (DXCM) and Nextpower Inc. (NXT). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $909.4M, roughly 1.4× Nextpower Inc.). Dexcom runs the higher net margin — 21.2% vs 14.4%, a 6.8% gap on every dollar of revenue. On growth, Nextpower Inc. posted the faster year-over-year revenue change (33.9% vs 21.6%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 11.1%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Nextpower Inc. (NXT) is a global energy technology provider based in Fremont, California.
DXCM vs NXT — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $909.4M |
| Net Profit | $267.3M | $131.2M |
| Gross Margin | 62.9% | 31.7% |
| Operating Margin | 25.6% | 19.4% |
| Net Margin | 21.2% | 14.4% |
| Revenue YoY | 21.6% | 33.9% |
| Net Profit YoY | 153.6% | 13.8% |
| EPS (diluted) | $0.67 | $0.85 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $909.4M | ||
| Q3 25 | $1.2B | $905.3M | ||
| Q2 25 | $1.2B | $864.3M | ||
| Q1 25 | $1.0B | $924.3M | ||
| Q4 24 | $1.1B | $679.4M | ||
| Q3 24 | $994.2M | $635.6M | ||
| Q2 24 | $1.0B | $719.9M |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $131.2M | ||
| Q3 25 | $283.8M | $146.9M | ||
| Q2 25 | $179.8M | $157.2M | ||
| Q1 25 | $105.4M | $156.8M | ||
| Q4 24 | $151.7M | $115.3M | ||
| Q3 24 | $134.6M | $115.4M | ||
| Q2 24 | $143.5M | $121.7M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | 31.7% | ||
| Q3 25 | 60.5% | 32.4% | ||
| Q2 25 | 59.5% | 32.6% | ||
| Q1 25 | 56.9% | 33.1% | ||
| Q4 24 | 58.9% | 35.5% | ||
| Q3 24 | 59.7% | 35.4% | ||
| Q2 24 | 62.4% | 33.0% |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 19.4% | ||
| Q3 25 | 20.1% | 20.0% | ||
| Q2 25 | 18.4% | 21.5% | ||
| Q1 25 | 12.9% | 21.1% | ||
| Q4 24 | 17.0% | 22.1% | ||
| Q3 24 | 15.3% | 21.0% | ||
| Q2 24 | 15.7% | 22.2% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 14.4% | ||
| Q3 25 | 23.5% | 16.2% | ||
| Q2 25 | 15.5% | 18.2% | ||
| Q1 25 | 10.2% | 17.0% | ||
| Q4 24 | 13.6% | 17.0% | ||
| Q3 24 | 13.5% | 18.2% | ||
| Q2 24 | 14.3% | 16.9% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $0.85 | ||
| Q3 25 | $0.70 | $0.97 | ||
| Q2 25 | $0.45 | $1.04 | ||
| Q1 25 | $0.27 | $1.05 | ||
| Q4 24 | $0.37 | $0.79 | ||
| Q3 24 | $0.34 | $0.79 | ||
| Q2 24 | $0.35 | $0.84 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $952.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $2.2B |
| Total Assets | $6.3B | $3.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $952.6M | ||
| Q3 25 | $1.8B | $845.3M | ||
| Q2 25 | $1.2B | $743.4M | ||
| Q1 25 | $904.9M | $766.1M | ||
| Q4 24 | $606.1M | $693.5M | ||
| Q3 24 | $621.2M | $561.9M | ||
| Q2 24 | $939.2M | $471.9M |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $2.2B | ||
| Q3 25 | $2.7B | $2.0B | ||
| Q2 25 | $2.6B | $1.8B | ||
| Q1 25 | $2.3B | $1.6B | ||
| Q4 24 | $2.1B | $1.4B | ||
| Q3 24 | $2.0B | $1.3B | ||
| Q2 24 | $2.4B | $1.1B |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $3.8B | ||
| Q3 25 | $7.5B | $3.7B | ||
| Q2 25 | $7.3B | $3.4B | ||
| Q1 25 | $6.8B | $3.2B | ||
| Q4 24 | $6.5B | $3.0B | ||
| Q3 24 | $6.4B | $2.8B | ||
| Q2 24 | $6.8B | $2.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $123.3M |
| Free Cash FlowOCF − Capex | — | $118.5M |
| FCF MarginFCF / Revenue | — | 13.0% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | — | 0.94× |
| TTM Free Cash FlowTrailing 4 quarters | — | $587.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $123.3M | ||
| Q3 25 | $659.9M | $186.9M | ||
| Q2 25 | $303.0M | $81.3M | ||
| Q1 25 | $183.8M | $237.3M | ||
| Q4 24 | $301.4M | $143.8M | ||
| Q3 24 | $199.5M | $153.8M | ||
| Q2 24 | $279.4M | $120.8M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $118.5M | ||
| Q3 25 | $579.4M | $171.4M | ||
| Q2 25 | $208.9M | $70.1M | ||
| Q1 25 | $96.8M | $227.2M | ||
| Q4 24 | $176.8M | $134.9M | ||
| Q3 24 | $88.3M | $141.8M | ||
| Q2 24 | $213.3M | $118.0M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 13.0% | ||
| Q3 25 | 47.9% | 18.9% | ||
| Q2 25 | 18.1% | 8.1% | ||
| Q1 25 | 9.3% | 24.6% | ||
| Q4 24 | 15.9% | 19.9% | ||
| Q3 24 | 8.9% | 22.3% | ||
| Q2 24 | 21.2% | 16.4% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 0.5% | ||
| Q3 25 | 6.7% | 1.7% | ||
| Q2 25 | 8.1% | 1.3% | ||
| Q1 25 | 8.4% | 1.1% | ||
| Q4 24 | 11.2% | 1.3% | ||
| Q3 24 | 11.2% | 1.9% | ||
| Q2 24 | 6.6% | 0.4% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 0.94× | ||
| Q3 25 | 2.33× | 1.27× | ||
| Q2 25 | 1.69× | 0.52× | ||
| Q1 25 | 1.74× | 1.51× | ||
| Q4 24 | 1.99× | 1.25× | ||
| Q3 24 | 1.48× | 1.33× | ||
| Q2 24 | 1.95× | 0.99× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
NXT
| Transferred Over Time | $763.9M | 84% |
| Transferred At Point In Time | $145.4M | 16% |
